Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ischemic Heart Disease

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 167 articles:
HTML format
Text format



Single Articles


    October 2019
  1. JNEID H
    Ticagrelor or Prasugrel in Acute Coronary Syndromes - The Winner Takes It All?
    N Engl J Med. 2019;381:1582-1585.
    PubMed     Text format    


  2. MICHOS ED, McEvoy JW, Blumenthal RS
    Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease.
    N Engl J Med. 2019;381:1557-1567.
    PubMed     Text format    


  3. KOBER L, Engstrom T
    A More COMPLETE Picture of Revascularization in STEMI.
    N Engl J Med. 2019;381:1472-1474.
    PubMed     Text format    


    September 2019
  4. STONE GW, Kappetein AP, Sabik JF, Pocock SJ, et al
    Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
    N Engl J Med. 2019 Sep 28. doi: 10.1056/NEJMoa1909406.
    PubMed     Text format     Abstract available


  5. MUNOZ D, Uzoije P, Reynolds C, Miller R, et al
    Polypill for Cardiovascular Disease Prevention in an Underserved Population.
    N Engl J Med. 2019;381:1114-1123.
    PubMed     Text format     Abstract available


  6. YASUDA S, Kaikita K, Akao M, Ako J, et al
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019 Sep 2. doi: 10.1056/NEJMoa1904143.
    PubMed     Text format     Abstract available


  7. BECKER RC
    Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease.
    N Engl J Med. 2019 Sep 2. doi: 10.1056/NEJMe1910560.
    PubMed     Text format    


  8. STEG PG, Bhatt DL, Simon T, Fox K, et al
    Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1908077.
    PubMed     Text format     Abstract available


  9. BATES ER
    Antiplatelet Therapy in Patients with Coronary Disease and Type 2 Diabetes.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMe1910813.
    PubMed     Text format    


  10. MEHTA SR, Wood DA, Storey RF, Mehran R, et al
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1907775.
    PubMed     Text format     Abstract available


  11. SCHUPKE S, Neumann FJ, Menichelli M, Mayer K, et al
    Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1908973.
    PubMed     Text format     Abstract available


    August 2019
  12. PANZA JA, Ellis AM, Al-Khalidi HR, Holly TA, et al
    Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
    N Engl J Med. 2019;381:739-748.
    PubMed     Text format     Abstract available


    July 2019
  13. HARDIN CC, Malhotra R, Petranovic M, Klassen S, et al
    Case 23-2019: A 52-Year-Old Man with Fever, Cough, and Hypoxemia.
    N Engl J Med. 2019;381:359-369.
    PubMed     Text format    


  14. FLINT AC, Conell C, Ren X, Banki NM, et al
    Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes.
    N Engl J Med. 2019;381:243-251.
    PubMed     Text format     Abstract available


  15. LEMKES JS, Janssens GN, van Royen N
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation. Reply.
    N Engl J Med. 2019;381:189-190.
    PubMed     Text format    


  16. DE SILVA K, Perera D
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:189.
    PubMed     Text format    


  17. KIM YJ, Kim WY
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:189.
    PubMed     Text format    


  18. WALDMANN V, Bonnet G, Spaulding C
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:188-189.
    PubMed     Text format    


  19. DEGRELL P, Varenne O
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:188.
    PubMed     Text format    


    June 2019
  20. NEUMANN JT, Twerenbold R, Ojeda F, Sorensen NA, et al
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
    N Engl J Med. 2019;380:2529-2540.
    PubMed     Text format     Abstract available


  21. NAGEL E, Greenwood JP, McCann GP, Bettencourt N, et al
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
    N Engl J Med. 2019;380:2418-2428.
    PubMed     Text format     Abstract available


  22. HUSAIN M, Birkenfeld AL, Donsmark M, Dungan K, et al
    Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2019 Jun 11. doi: 10.1056/NEJMoa1901118.
    PubMed     Text format     Abstract available


  23. RIDKER PM
    Methotrexate for Prevention of Cardiovascular Events. Reply.
    N Engl J Med. 2019;380:2277.
    PubMed     Text format    


  24. HUANG Y, Chan AW, Shear NH
    Methotrexate for Prevention of Cardiovascular Events.
    N Engl J Med. 2019;380:2277.
    PubMed     Text format    


  25. VAN VOLLENHOVEN RF, Nurmohamed M
    Methotrexate for Prevention of Cardiovascular Events.
    N Engl J Med. 2019;380:2276-2277.
    PubMed     Text format    


    May 2019
  26. DE LA FUENTE J, Bird J
    Coronary Arteritis in IgG4-Related Disease.
    N Engl J Med. 2019;380:2156.
    PubMed     Text format    


  27. YU D, Blair JEA
    A STEMI Mimic.
    N Engl J Med. 2019;380:e41.
    PubMed     Text format    


  28. SCHWARTZ GG, Steg PG, Szarek M
    Alirocumab after Acute Coronary Syndrome. Reply.
    N Engl J Med. 2019;380:2077.
    PubMed     Text format    


  29. PIGNATELLI P, Camera M, Violi F
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2076.
    PubMed     Text format    


  30. ENNEZAT PV, Hansen MR
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2076.
    PubMed     Text format    


  31. LAN NSR, Yeap BB, Fegan PG
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2075-2076.
    PubMed     Text format    


  32. ALKHALIL M
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2075.
    PubMed     Text format    


  33. GAO Y, Hou B
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2074-2075.
    PubMed     Text format    


  34. THIELE H, Schneider S, Desch S
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock. Reply.
    N Engl J Med. 2019;380:1877.
    PubMed     Text format    


  35. YAN F, Thall P, Yuan Y
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
    N Engl J Med. 2019;380:1876-1877.
    PubMed     Text format    


  36. WIVIOTT SD, Raz I, Sabatine MS
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. Reply.
    N Engl J Med. 2019;380:1881-1882.
    PubMed     Text format    


  37. AKINCI B
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2019;380:1881.
    PubMed     Text format    


  38. BAGLIONI P
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2019;380:1880-1881.
    PubMed     Text format    


    April 2019
  39. BHATT DL, Steg PG, Miller M
    Cardiovascular Risk Reduction with Icosapent Ethyl. Reply.
    N Engl J Med. 2019;380:1678.
    PubMed     Text format    


  40. BORGHI C, Fogacci F, Cicero AFG
    Cardiovascular Risk Reduction with Icosapent Ethyl.
    N Engl J Med. 2019;380:1678.
    PubMed     Text format    


  41. CHAN LN
    Cardiovascular Risk Reduction with Icosapent Ethyl.
    N Engl J Med. 2019;380:1677.
    PubMed     Text format    


  42. MUSHER DM, Abers MS, Corrales-Medina VF
    Acute Infection and Myocardial Infarction. Reply.
    N Engl J Med. 2019;380.
    PubMed     Text format    


  43. FRANK RC, Hanidziar D
    Acute Infection and Myocardial Infarction.
    N Engl J Med. 2019;380.
    PubMed     Text format    


    March 2019
  44. LANDONI G, Lomivorotov VV, Nigro Neto C, Monaco F, et al
    Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery.
    N Engl J Med. 2019 Mar 19. doi: 10.1056/NEJMoa1816476.
    PubMed     Text format     Abstract available


  45. LEMKES JS, Janssens GN, van der Hoeven NW, Jewbali LSD, et al
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019 Mar 18. doi: 10.1056/NEJMoa1816897.
    PubMed     Text format     Abstract available


  46. ABELLA BS, Gaieski DF
    Coronary Angiography after Cardiac Arrest - The Right Timing or the Right Patients?
    N Engl J Med. 2019 Mar 18. doi: 10.1056/NEJMe1901651.
    PubMed     Text format    


  47. LOPES RD, Heizer G, Aronson R, Vora AN, et al
    Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMoa1817083.
    PubMed     Text format     Abstract available


  48. MEHTA SR
    Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndromes or PCI.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMe1902214.
    PubMed     Text format    


  49. FERENCE BA, Ray KK, Catapano AL, Ference TB, et al
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2019;380:1033-1042.
    PubMed     Text format     Abstract available


  50. OH J, Kang SM
    Rivaroxaban in Patients with Heart Failure.
    N Engl J Med. 2019;380:988.
    PubMed     Text format    


    February 2019
  51. RIDKER PM, Everett BM, Pradhan A, MacFadyen JG, et al
    Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
    N Engl J Med. 2019;380:752-762.
    PubMed     Text format     Abstract available


  52. FAUCHIER L, Clementy N, Bisson A
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2019;380:600.
    PubMed     Text format    


  53. STECKER EC, Walsh MN
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2019;380:599.
    PubMed     Text format    



  54. Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2019;380:599-601.
    PubMed     Text format    


    January 2019
  55. TAGGART DP, Benedetto U, Gerry S, Altman DG, et al
    Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years.
    N Engl J Med. 2019;380:437-446.
    PubMed     Text format     Abstract available



  56. Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298-300.
    PubMed     Text format    


  57. CHEUNG BMY
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:299-300.
    PubMed     Text format    


  58. SANDHU AT, Maron DJ
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:299.
    PubMed     Text format    


  59. BOGATY P, Brophy J
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298-9.
    PubMed     Text format    


  60. KOROSOGLOU G, Giusca S
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298.
    PubMed     Text format    


  61. MUSHER DM, Abers MS, Corrales-Medina VF
    Acute Infection and Myocardial Infarction.
    N Engl J Med. 2019;380:171-176.
    PubMed     Text format    


  62. VERMA S, Mazer CD
    Open or Endoscopic Vein Harvesting for Coronary-Artery Bypass Grafting.
    N Engl J Med. 2019;380:189-191.
    PubMed     Text format    


    December 2018
  63. MATSUURA H, Ohya M
    Coronary-Artery Occlusion from Kawasaki's Disease.
    N Engl J Med. 2018;379:e42.
    PubMed     Text format    


  64. WADHERA RK, Bhatt DL
    Toward Precision Policy - The Case of Cardiovascular Care.
    N Engl J Med. 2018;379:2193-2195.
    PubMed     Text format    


    November 2018
  65. BURNETT JR, Hooper AJ
    PCSK9 - A Journey to Cardiovascular Outcomes.
    N Engl J Med. 2018;379:2161-2162.
    PubMed     Text format    


  66. KOPJAR T, Gasparovic H, Biocina B
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966-7.
    PubMed     Text format    


  67. REHMAN SM, Duggan SMJ
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966.
    PubMed     Text format    


  68. ALSAGHEIR A, Belley-Cote EP, Whitlock RP
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966.
    PubMed     Text format    



  69. Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966-1968.
    PubMed     Text format    


  70. ZENATI MA, Bhatt DL, Bakaeen FG, Stock EM, et al
    Randomized Trial of Endoscopic or Open Vein-Graft Harvesting for Coronary-Artery Bypass.
    N Engl J Med. 2018 Nov 11. doi: 10.1056/NEJMoa1812390.
    PubMed     Text format     Abstract available


  71. MANSON JE, Cook NR, Lee IM, Christen W, et al
    Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1811403.
    PubMed     Text format     Abstract available


  72. MANSON JE, Cook NR, Lee IM, Christen W, et al
    Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1809944.
    PubMed     Text format     Abstract available


  73. BHATT DL, Steg PG, Miller M, Brinton EA, et al
    Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812792.
    PubMed     Text format     Abstract available


  74. WIVIOTT SD, Raz I, Bonaca MP, Mosenzon O, et al
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812389.
    PubMed     Text format     Abstract available


  75. SCHWARTZ GG, Steg PG, Szarek M, Bhatt DL, et al
    Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
    N Engl J Med. 2018 Nov 7. doi: 10.1056/NEJMoa1801174.
    PubMed     Text format     Abstract available


  76. ADRIAENSSENS T, Van de Werf F
    Is Culprit-Lesion-Only PCI in Cardiogenic Shock Still Better at 1 Year?
    N Engl J Med. 2018;379:1775-1776.
    PubMed     Text format    


  77. THIELE H, Akin I, Sandri M, de Waha-Thiele S, et al
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
    N Engl J Med. 2018;379:1699-1710.
    PubMed     Text format     Abstract available


    October 2018

  78. Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1582-1584.
    PubMed     Text format    


  79. MONTENEGRO MF, Lundberg JO, Weitzberg E
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1583-4.
    PubMed     Text format    


  80. PEREZ-GOMEZ MV, Bartsch LA, Ortiz A
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1583.
    PubMed     Text format    


  81. BHATTACHARYYA S, Macklin EA, Schwarzschild MA
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1582.
    PubMed     Text format    


  82. DRAZEN JM
    Expression of Concern: Beltrami AP et al. Evidence That Human Cardiac Myocytes Divide after Myocardial Infarction. N Engl J Med 2001;344:1750-7 and Quaini F et al. Chimerism of the Transplanted Heart. N Engl J Med 2002;346:5-15.
    N Engl J Med. 2018 Oct 17. doi: 10.1056/NEJMe1813801.
    PubMed     Text format    



  83. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
    N Engl J Med. 2018;379:1486.
    PubMed     Text format    



  84. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387-1389.
    PubMed     Text format    


  85. STEWART RAH
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1388.
    PubMed     Text format    


  86. JENKINS D, Sievenpiper J, Jones P
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387-8.
    PubMed     Text format    


  87. CORREIA LCL
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387.
    PubMed     Text format    


    September 2018
  88. FIELD ME, Page RL
    Another Shock for Sudden Death Prevention after Myocardial Infarction.
    N Engl J Med. 2018;379:1274-1275.
    PubMed     Text format    


  89. OLGIN JE, Pletcher MJ, Vittinghoff E, Wranicz J, et al
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2018;379:1205-1215.
    PubMed     Text format     Abstract available


  90. MCNEIL JJ, Wolfe R, Woods RL, Tonkin AM, et al
    Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
    N Engl J Med. 2018 Sep 16. doi: 10.1056/NEJMoa1805819.
    PubMed     Text format     Abstract available


    August 2018
  91. ZANNAD F, Anker SD, Byra WM, Cleland JGF, et al
    Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.
    N Engl J Med. 2018 Aug 27. doi: 10.1056/NEJMoa1808848.
    PubMed     Text format     Abstract available


  92. BOHULA EA, Wiviott SD, McGuire DK, Inzucchi SE, et al
    Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808721.
    PubMed     Text format     Abstract available


  93. MAZER CD, Whitlock RP, Fergusson DA, Belley-Cote E, et al
    Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808561.
    PubMed     Text format     Abstract available



  94. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.
    N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMoa1805971.
    PubMed     Text format     Abstract available


  95. HOFFMANN U, Udelson JE
    Imaging Coronary Anatomy and Reducing Myocardial Infarction.
    N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMe1809203.
    PubMed     Text format    


  96. RAWSHANI A, Rawshani A, Franzen S, Sattar N, et al
    Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2018;379:633-644.
    PubMed     Text format     Abstract available


  97. WEINER RB, Hucker WJ, Meyersohn NM, Dudzinski DM, et al
    Case 25-2018: A 63-Year-Old Man with Syncope.
    N Engl J Med. 2018;379:670-680.
    PubMed     Text format    


    July 2018
  98. XAPLANTERIS P, Fournier S, Pijls NHJ, Fearon WF, et al
    Five-Year Outcomes with PCI Guided by Fractional Flow Reserve.
    N Engl J Med. 2018;379:250-259.
    PubMed     Text format     Abstract available


    June 2018
  99. CUERVO G, Viasus D, Carratala J
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2540.
    PubMed     Text format    


  100. BUCKLEY LF
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539-40.
    PubMed     Text format    


  101. CASTILLO-RODRIGUEZ E, Fernandez-Prado R, Ortiz A
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539.
    PubMed     Text format    


  102. WIESSMAN M, Shlomai A
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539.
    PubMed     Text format    


  103. WAXMAN DA, Kanzaria HK, Schriger DL
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2538-9.
    PubMed     Text format    



  104. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2538-2541.
    PubMed     Text format    


  105. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
    Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMc1806491.
    PubMed     Text format    


  106. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMoa1800389.
    PubMed     Text format     Abstract available


  107. ARBOINE L, Palacios JM
    Left Main Coronary Artery Aneurysm.
    N Engl J Med. 2018;378:e32.
    PubMed     Text format    


    May 2018
  108. SHAPIRA OM
    Radial Artery as the Preferred Second Conduit for Coronary Bypass.
    N Engl J Med. 2018;378:2134-2135.
    PubMed     Text format    


  109. JOHNSTON SC, Easton JD, Farrant M, Barsan W, et al
    Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1800410.
    PubMed     Text format     Abstract available


    April 2018
  110. GAUDINO M, Benedetto U, Fremes S, Biondi-Zoccai G, et al
    Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018 Apr 30. doi: 10.1056/NEJMoa1716026.
    PubMed     Text format     Abstract available


  111. CAMPBELL BCV, Mitchell PJ, Churilov L, Yassi N, et al
    Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    N Engl J Med. 2018;378:1573-1582.
    PubMed     Text format     Abstract available


  112. BAIRD AE
    Paving the Way for Improved Treatment of Acute Stroke with Tenecteplase.
    N Engl J Med. 2018;378:1635-1636.
    PubMed     Text format    


  113. ZHAO YT, Huang YS
    ECG Pattern Associated with Left Anterior Descending Coronary Artery Occlusion.
    N Engl J Med. 2018;378:e22.
    PubMed     Text format    


  114. AMELOOT K, Daemen J, Van Mieghem N
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1360-1.
    PubMed     Text format    


  115. PAPPALARDO F, Bertoldi L
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1360.
    PubMed     Text format    


  116. PASCERI V, Pelliccia F, Speciale G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359-60.
    PubMed     Text format    


  117. FERREIRA RM, Salis LHA, e Silva NAS
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359.
    PubMed     Text format    


  118. FLEISSNER F, Haverich A, Warnecke G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358-9.
    PubMed     Text format    


  119. SHARMA S, Lardizabal J
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358.
    PubMed     Text format    



  120. PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358-1361.
    PubMed     Text format    


    March 2018
  121. LOSCALZO J, Roy N, Shah RV, Tsai JN, et al
    Case 8-2018: A 55-Year-Old Woman with Shock and Labile Blood Pressure.
    N Engl J Med. 2018;378:1043-1053.
    PubMed     Text format    


  122. WHITE WB, Saag KG, Becker MA, Borer JS, et al
    Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
    N Engl J Med. 2018 Mar 12. doi: 10.1056/NEJMoa1710895.
    PubMed     Text format     Abstract available


  123. LEE F, Maggiore P, Chung K
    Self-Management of an Inferior ST-Segment Elevation Myocardial Infarction.
    N Engl J Med. 2018;378:960-962.
    PubMed     Text format    


    February 2018

  124. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2018;378:782.
    PubMed     Text format    


    January 2018
  125. FAUCHIER L, Bisson A, Angoulvant D
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395.
    PubMed     Text format    


  126. KWONG JC, Schwartz KL, Campitelli MA, Chung H, et al
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:345-353.
    PubMed     Text format     Abstract available


  127. CAHILL TJ, Wijesurendra RS, Casadei B
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:397.
    PubMed     Text format    


  128. HELFT G, Le Feuvre C, Zaman A
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:397.
    PubMed     Text format    


  129. JEONG YH, Bae JS, Gurbel PA
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:396.
    PubMed     Text format    


  130. AJANI AE
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395-6.
    PubMed     Text format    



  131. Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395-398.
    PubMed     Text format    


  132. FAUCHIER L, Bisson A, Angoulvant D
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395.
    PubMed     Text format    


  133. WEBSTER MWI, Stables RH
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:299.
    PubMed     Text format    


  134. SHAH R
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:299.
    PubMed     Text format    


  135. VIJ A, Kodumuri V
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298.
    PubMed     Text format    


  136. BULLUCK H
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298.
    PubMed     Text format    



  137. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298-301.
    PubMed     Text format    


  138. STONE GW
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:300-1.
    PubMed     Text format    



  139. Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:200-202.
    PubMed     Text format    


  140. LELLOUCHE F, Simon M, L'Her E
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:201.
    PubMed     Text format    


  141. SAMADANI U, Affana CK
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:200-1.
    PubMed     Text format    


  142. ROSENBAUM L
    Swallowing a Spy - The Potential Uses of Digital Adherence Monitoring.
    N Engl J Med. 2018;378:101-103.
    PubMed     Text format    


    December 2017
  143. IMPRIALOS KP, Stavropoulos K, Doumas M
    Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:2502.
    PubMed     Text format    


  144. HOLMAN RR, Bethel MA, Hernandez AF
    Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:2502.
    PubMed     Text format    


  145. TSIARAS SV, Safi LM, Ghoshhajra BB, Lindsay ME, et al
    Case 39-2017. A 41-Year-Old Woman with Recurrent Chest Pain.
    N Engl J Med. 2017;377:2475-2484.
    PubMed     Text format    


  146. KELLY NP, Gerhard-Herman M, Desai AS, Miller AL, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:2267-2272.
    PubMed     Text format    


    November 2017

  147. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2097-2099.
    PubMed     Text format    


  148. RAJAGOPALAN S, Brook R
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2098-9.
    PubMed     Text format    


  149. FERNANDEZBALSELLS MM, Sojo-Vega L, Ricart-Engel W
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2098.
    PubMed     Text format    


  150. BAGLIONI P
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2097-8.
    PubMed     Text format    


  151. KELLY NP, Vaidya A, Gerhard-Herman M, Desai AS, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:e29.
    PubMed     Text format    


  152. MAZER CD, Whitlock RP, Fergusson DA, Hall J, et al
    Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.
    N Engl J Med. 2017 Nov 12. doi: 10.1056/NEJMoa1711818.
    PubMed     Text format     Abstract available


  153. JACOB KA, Gianoli M, van Dijk D
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897-8.
    PubMed     Text format    


  154. TAGGART DP, Puskas JD
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897.
    PubMed     Text format    


  155. JONES SG, Pullan MD, Kirmani BH
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1896-7.
    PubMed     Text format    


  156. NOZAWA T, Imagawa T, Ito S
    Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki's Disease.
    N Engl J Med. 2017;377:1894-1896.
    PubMed     Text format    



  157. Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1898-1899.
    PubMed     Text format    


    October 2017
  158. THIELE H, Akin I, Sandri M, Fuernau G, et al
    PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.
    N Engl J Med. 2017 Oct 30. doi: 10.1056/NEJMoa1710261.
    PubMed     Text format     Abstract available


  159. MONTONE RA, Minelli S
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595-6.
    PubMed     Text format    


  160. AGGARWAL S, Pavlides G
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595.
    PubMed     Text format    


  161. BHATT DL
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1598-1599.
    PubMed     Text format    


  162. DAVIES JE, Sen S, Escaned J
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1597-1598.
    PubMed     Text format    


  163. PIJLS NHJ, De Bruyne B
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596.
    PubMed     Text format    



  164. Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596-7.
    PubMed     Text format    


    September 2017
  165. BOWMAN L, Hopewell JC, Chen F, Wallendszus K, et al
    Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
    N Engl J Med. 2017;377:1217-1227.
    PubMed     Text format     Abstract available


  166. RIDKER PM, Everett BM, Thuren T, MacFadyen JG, et al
    Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
    N Engl J Med. 2017;377:1119-1131.
    PubMed     Text format     Abstract available


  167. HOLMAN RR, Bethel MA, Mentz RJ, Thompson VP, et al
    Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017 Sep 14. doi: 10.1056/NEJMoa1612917.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: